QVR’s AbbVie ABBV Stock Holding History

QVR’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,805	Closed	-$844K	–	157
2025 Q4	$869K	Sell	3,805 -8,325	-69%	-$1.9M	0.04%	49
2025 Q3	$2.81M	Buy	+12,130	New	+$2.47M	0.34%	19
2022 Q4	–	Sell	-7,754	Closed	-$1.19M	–	195
2022 Q3	$1.04M	Buy	+7,754	New	+$1.11M	0.09%	188
2021 Q4	–	Sell	-3,599	Closed	-$388K	–	19
2021 Q3	$388K	Buy	3,599 +3,133	+672%	+$358K	0.03%	259
2021 Q2	$52K	Buy	+466	New	+$52.5K	0.01%	251
2021 Q1	–	Sell	-542	Closed	-$58K	–	246
2020 Q4	$58K	Buy	+542	New	+$52.1K	0.01%	123

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

QVR's ABBV Position: Q1 2026 in Review

QVR sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 3,805 shares — an estimated $844K sold.

QVR first reported a position in ABBV in Q4 2020 and held it in 6 quarters. The position peaked at $2.81M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

QVR reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
QVR sold 3,805 AbbVie shares in Q1 2026, an estimated $844K.
QVR first reported a position in AbbVie in Q4 2020 and held it in 6 quarters.
QVR's AbbVie position peaked at $2.81M in Q3 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on QVR's 13F filing for Q1 2026, filed 15 Apr 2026.